Recomendaciones para el manejo de los pacientes críticos con COVID-19 en las Unidades de Cuidados Intensivos
Tóm tắt
Từ khóa
Tài liệu tham khảo
WHO. Director-General's opening remarks at the media briefing on COVID-19-11 March 2020 [Internet]. [consultado 13 Abr 2020]. Disponible en: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
World Health Organization. Coronavirus disease (COVID-19) – World Health Organization [Internet]. [consultado 22 May 2021]. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Grasselli, 2020, Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy, JAMA., 323, 1574, 10.1001/jama.2020.5394
Bhatraju, 2020, Covid-19 in Critically Ill Patients in the Seattle Region - Case Series, N Engl J Med., 382, 2012, 10.1056/NEJMoa2004500
Arentz, 2020, Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State, JAMA., 323, 1612, 10.1001/jama.2020.4326
Xie, 2020, Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study, Intensive Care Med., 46, 1863, 10.1007/s00134-020-06211-2
Barrasa, 2020, SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria, Anaesth Crit Care Pain Med., 39, 553, 10.1016/j.accpm.2020.04.001
Rodríguez, 2020, Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic, Med Intensiva., 44, 525, 10.1016/j.medin.2020.05.018
Ramírez, 2021, Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain, Med Intensiva., 45, 27, 10.1016/j.medin.2020.06.015
Vidal-Cortés, 2021, COVID-19 and Acute Respiratory Distress Syndrome. Impact of corticosteroid treatment and predictors of poor outcome, Rev Esp Quimioter., 34, 33, 10.37201/req/091.2020
Rodríguez, 2021, Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain, Crit Care., 25, 63, 10.1186/s13054-021-03487-8
Bravata, 2021, Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic, JAMA Netw Open., 4, e2034266, 10.1001/jamanetworkopen.2020.34266
Bhimraj, 2020, Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19, Clin Infect Dis.
Alhazzani, 2020, Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19), Intensive Care Med., 46, 854, 10.1007/s00134-020-06022-5
Bai, 2020, Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020), Eur Respir Rev., 29, 200287, 10.1183/16000617.0287-2020
Díaz, 2021, Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH), Med Intensiva, 45, 104, 10.1016/j.medin.2020.06.017
Kalil, 2020, Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics, JAMA., 323, 1897, 10.1001/jama.2020.4742
Estella, 2020, [From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic], Med Intensiva., 44, 509, 10.1016/j.medin.2020.04.009
Bhimraj A. Morgan R.L. Shumaker A.H. Lavergne V. Baden L. Cheng V.C.C.et al. COVID-19 Guideline, Part 1: Treatment and Management [Internet]. [consultado 18 Abr 2021]. Disponible en: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/